tiprankstipranks
Trending News
More News >
Hightide Therapeutics Inc (HK:2511)
:2511
Hong Kong Market

Hightide Therapeutics Inc (2511) Income Statement

Compare
0 Followers

Hightide Therapeutics Inc Income Statement

Last quarter (Q4 2024), Hightide Therapeutics Inc's total revenue was ¥0.00, a decrease of ― from the same quarter last year. In Q4, Hightide Therapeutics Inc's net income was ¥―. See Hightide Therapeutics Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 0.00¥ 0.00¥ 0.00¥ 0.00
Gross Profit
¥ 0.00---
Operating Expenses
¥ 444.75K¥ 438.34M¥ 229.56M¥ 128.33M
Depreciation and Amortization
¥ 537.00¥ 1.83M--
EBITDA
¥ -444.22K¥ -959.43M¥ -229.56M¥ -128.33M
Operating Income
¥ -444.75K¥ -440.36M¥ -230.86M¥ -129.89M
Other Income/Expenses
¥ 63.23K¥ -498.87M¥ 36.64M¥ -79.07M
Pretax Income
¥ -381.52K¥ -939.23M¥ -194.22M¥ -217.39M
Net Income
¥ -381.79K¥ -939.31M¥ -194.25M¥ -217.49M
Per Share Metrics
Basic EPS
¥ -0.84¥ -2.02¥ -0.38¥ -0.42
Diluted EPS
¥ -0.84¥ -2.02¥ -0.38¥ -0.42
Weighted Average Shares Outstanding
452.08M 259.69M 514.77M 514.77M
Weighted Average Shares Outstanding (Diluted)
452.08M 259.69M 514.77M 514.77M
Currency in CNY

Hightide Therapeutics Inc Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis